New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD ...

The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on ...

The company is dedicated to maintaining the highest quality and regulatory standards while supporting smooth global business ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

An Indian drug maker tells a BBC undercover team its addictive cocktail drug is “very harmful” but “this is business”.

The EU's competition chief says U.S. President Donald Trump has upended the "trustful relationship" between the United States ...

LONDON, UK / ACCESS Newswire / February 19, 2025 /NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY ...

Q4 2024 Earnings Call Transcript February 19, 2025 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is ...

The World Health Organization released new findings on Friday about an "alarming" lack of awareness about alcohol's link to ...

CROPrime, a specialist in clinical trial site selection and feasibility, is offering its expertise to biotech and pharmaceutical companies seeking to collaborate with leading UK hospitals for their ...

In the backdrop of the US-India dialogue on tariffs, the Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian ...